查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572032

葡萄糖生物感測器的全球市場

Glucose Biosensors
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球葡萄糖生物感測器市場將達到41億美元

葡萄糖生物感測器的全球市場預計到 2023 年將達到 36 億美元，預計到 2030 年將達到 41 億美元，在 2023-2030 年分析期間複合年成長率為 2.1%。醫院最終用途是本報告分析的細分市場之一，預計複合年成長率為 1.8%，到分析期結束時將達到 15 億美元。在分析期間，居家照護診斷最終用途行業的複合年成長率預計為 2.5%。

美國市場預估達9.603億美元，中國預計複合年成長率為3.1%

預計 2023 年美國葡萄糖生物感測器市場規模將達到 9.603 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到7.656億美元，2023-2030年分析期間複合年成長率為3.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 1.5% 和 1.9%。在歐洲，德國的複合年成長率預計為 1.8%。

全球葡萄糖生物感測器市場—主要趨勢和促進因素總結

葡萄糖生物感測器如何增強糖尿病管理？

血糖生物感測器是糖尿病管理的重要工具，為患者提供即時血糖值監測。這些感測器對於血糖儀和連續血糖監測 (CGM) 設備至關重要，它們使用酶促反應和電化學檢測方法來測量血液中的血糖水平。具有 24 小時追蹤功能的連續血糖監測系統可以為患者提供更多資料，以做出有關胰島素劑量、飲食和活動改善的明智決策，從而顯著改善糖尿病管理。隨著全球糖尿病盛行率的不斷上升，對準確、可靠和方便用戶使用的葡萄糖生物感測器的需求不斷增加，以幫助患者更好地控制疾病。

葡萄糖生物感測器的主要細分領域和應用有哪些？

葡萄糖生物感測器市場按電化學生物感測器、光學生物感測器和酵素生物感測器等技術細分。電化學生物感測器透過酵素反應產生的電訊號測量葡萄糖濃度，由於其準確性、經濟性以及在 CGM 設備和血糖儀中的廣泛使用，在市場上佔據主導地位。使用基於光的檢測方法的光學生物感測器也越來越受歡迎，特別是對於非侵入性監測系統。從應用來看，葡萄糖生物感測器主要應用於自我血糖監測（SMBG）系統和連續血糖監測設備。主要的最終用戶是醫院、診所和居家醫療。北美地區因其高患病率和發達的醫療基礎設施而引領市場，而亞太地區則由於糖尿病患病率上升和醫療保健機會的改善而經歷快速成長。

科技進步如何影響葡萄糖生物感測器？

技術創新正在推動葡萄糖生物感測器的改進，特別是在非侵入性監測、感測器準確性以及與數位健康平台整合等領域。透過穿戴式感測器提供即時資料的連續血糖監測 (CGM) 系統減少了頻繁的指尖採血測試的需要，徹底改變了糖尿病管理。感測器小型化、生物相容性材料和無線連接的進步使這些設備對患者來說更加舒適和方便。透過將葡萄糖生物感測器與行動應用程式和雲端平台整合，患者和醫療保健提供者可以追蹤趨勢並做出資料驅動的決策。此外，對光學和經皮感測器等非侵入性血糖監測方法的研究為糖尿病治療的未來帶來了希望。

推動葡萄糖生物感測器市場成長的因素有哪些？

葡萄糖生物感測器市場的成長受到多種因素的推動，例如全球糖尿病盛行率的上升以及對連續即時血糖監測解決方案的需求不斷增加。生物感測器技術的進步，包括感測器精度的提高、小型化和非侵入性監測技術，正在改善患者體驗並擴大葡萄糖生物感測器在臨床和家庭環境中的使用。旨在改善糖尿病管理的政府措施和醫療保健政策進一步推動了先進血糖監測設備的採用。葡萄糖生物感測器和數位健康平台的日益整合，以改善患者和醫療保健提供者的溝通和資料分析，也推動了市場成長。

調查企業範例（共42例）

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi SA

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP21894

Global Glucose Biosensors Market to Reach US$4.1 Billion by 2030

The global market for Glucose Biosensors estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Homecare Diagnostics End-Use segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$960.3 Million While China is Forecast to Grow at 3.1% CAGR

The Glucose Biosensors market in the U.S. is estimated at US$960.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$765.6 Million by the year 2030 trailing a CAGR of 3.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Glucose Biosensors Market - Key Trends and Drivers Summarized

How Are Glucose Biosensors Enhancing Diabetes Management?

Glucose biosensors are critical tools in the management of diabetes, providing real-time monitoring of blood glucose levels for patients. These sensors, which are integral to glucose meters and continuous glucose monitoring (CGM) devices, measure the concentration of glucose in the blood using enzymatic reactions and electrochemical detection methods. Continuous glucose monitoring systems, which offer around-the-clock tracking, have significantly improved diabetes management by providing patients with more data to make informed decisions about their insulin dosing, diet, and activity. With the rising prevalence of diabetes worldwide, the demand for accurate, reliable, and user-friendly glucose biosensors is on the rise, helping patients maintain better control over their condition.

What Are the Key Segments and Applications of Glucose Biosensors?

The glucose biosensors market is segmented by technology, including electrochemical, optical, and enzymatic biosensors. Electrochemical biosensors, which measure glucose concentration through electrical signals generated by enzymatic reactions, dominate the market due to their accuracy, affordability, and widespread use in CGM devices and glucose meters. Optical biosensors, which use light-based detection methods, are also gaining traction, particularly for non-invasive monitoring systems. In terms of application, glucose biosensors are primarily used in self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring devices. Hospitals, clinics, and home healthcare settings represent the primary end-users. North America leads the market due to the high prevalence of diabetes and advanced healthcare infrastructure, while Asia-Pacific is experiencing rapid growth as diabetes rates rise and access to healthcare improves.

How Are Technological Advancements Impacting Glucose Biosensors?

Technological innovations are driving improvements in glucose biosensors, particularly in the areas of non-invasive monitoring, sensor accuracy, and integration with digital health platforms. Continuous glucose monitoring (CGM) systems, which provide real-time data through wearable sensors, have transformed diabetes management by reducing the need for frequent finger-prick tests. Advances in sensor miniaturization, biocompatible materials, and wireless connectivity are making these devices more comfortable and convenient for patients. The integration of glucose biosensors with mobile apps and cloud platforms is enabling patients and healthcare providers to track trends and make data-driven decisions. Additionally, research into non-invasive glucose monitoring methods, such as optical and transdermal sensors, holds promise for the future of diabetes care.

What Factors Are Driving the Growth in the Glucose Biosensors Market?

The growth in the glucose biosensors market is driven by several factors, including the rising global prevalence of diabetes and the increasing demand for continuous, real-time glucose monitoring solutions. Advances in biosensor technology, including improvements in sensor accuracy, miniaturization, and non-invasive monitoring techniques, are enhancing the patient experience and expanding the use of glucose biosensors in both clinical and home settings. Government initiatives and healthcare policies aimed at improving diabetes management are further supporting the adoption of advanced glucose monitoring devices. The growing integration of glucose biosensors with digital health platforms, enabling better patient-provider communication and data analysis, is also fueling market growth.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi S.A.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Glucose Biosensors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Propels Demand for Glucose Biosensors
    • Technological Innovations in Continuous Glucose Monitoring (CGM) Devices Strengthen Market Growth
    • Increasing Adoption of Wearable Glucose Biosensors Drives Market Expansion
    • Growing Focus on Non-Invasive Glucose Monitoring Technologies Creates Opportunities
    • Rising Demand for Portable and Convenient Glucose Monitoring Devices Expands Addressable Market
    • Advancements in Sensor Accuracy and Reliability Propel Adoption of Glucose Biosensors
    • Increasing Integration of Biosensors with Mobile Apps and Cloud Platforms Boosts Demand
    • Rising Adoption of Glucose Biosensors in Personalized Medicine Strengthens Business Case
    • Growing Preference for Continuous Glucose Monitoring over Traditional Testing Methods Drives Growth
    • Technological Developments in Miniaturized and Implantable Biosensors Spur Innovation
    • Rising Demand for Real-Time Monitoring Solutions in Healthcare Expands Market for Biosensors
    • Growing Healthcare Expenditure and Insurance Coverage for Diabetes Management Support Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Homecare Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Glucose Biosensors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION